Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

Search Blogs that Mention this News Release

Click this link to view linked Bookmarking Services

Click this link to view linked Blogging Services

Biosite(R) Incorporated to Conduct 3rd Quarter Results Conference Call

    Biosite Incorporated (Nasdaq: BSTE) announces the following Webcast:

    Biosite Incorporated will announce 2005 third quarter results on Tuesday,
October 25, 2005 following the close of the market.  The Company will also
webcast a conference call on the same day (October 25) at 1:30 p.m. Pacific.

      What:        Biosite Announces 3rd Quarter Results Conference Call

      When:        Tuesday, October 25, 2005 at 1:30 p.m. Pacific

      Where:       http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
eventDetails&c=69046&eventID=1143573
                   OR http://www.biosite.com

      How:         Live over the Internet -- Simply log onto the web at the
                   address above.

      Telephonic:  US/Canada/Int'l Dial #: (706) 634-7088
                   Conference ID# 9802947

                   You may dial *0 at any time for Operator assistance

      Contact:     Simona Dixon
                   Corporate and Investor Relations
                   Biosite Incorporated
                   858.805.2824
                   email: sdixon@biosite.com

     If you are unable to participate during the live webcast, the call will
be archived on the Biosite web site http://www.biosite.com until November 15, 2005.
The telephone replay number for U.S. callers is 800-642-1687.  International
callers can dial 706-645-9291, conference ID#9802947.

     Company press releases may be found at http://www.biosite.com

     About Biosite: A leader in the drive to advance diagnosis, Biosite
Incorporated is a research-based company dedicated to the discovery and
development of novel protein-based diagnostic tests that improve a physician's
ability to diagnose debilitating and life-threatening diseases.  The Company
combines integrated discovery and diagnostics businesses to access proteomics
research, identify proteins with high diagnostic utility, develop and
commercialize products and educate the medical community on new diagnostic
approaches that improve health care outcomes.  Biosite's Triage(R) brand rapid
diagnostic tests are used in approximately 50 percent of U.S. hospitals and in
more than 50 international markets. Information about Biosite can be found at
http://www.biosite.com.

    (Minimum Requirements to listen to broadcast:  The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/EN/default.asp
and at least a 28.8Kbps connection to the Internet.)

SOURCE Biosite Incorporated

http://www.biosite.com
Company News On-Call:

http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, VP, Corporate & Investor
Relations of Biosite Incorporated, +1-858-805-2820,
npadilla@biosite.com